TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024

Pharmaceutical products
UK
Published value
Not published
Submission deadline Not published
Lots published4
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024". Published status: complete. Published value: Value not published. 4 published lots. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityNHS EnglandScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence ยท Authority Profile: NHS England
Market Analytics
View Authority Profile โ†’
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
46.5Bids / Report
6.4% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 881 active published awards; 872 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS England
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published26 Feb 2024, 12:50 GMT
Last source update26 Feb 2024, 12:50 GMT
Recurring procurementNot published
ClassificationPharmaceutical products
Delivery area
UK
OCIDocds-h6vhtk-040e74
What is being bought
Project Title: NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024<br/> <br/>Offer reference number: CM/PHR/22/5678<br/> <br/>CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B. Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authorityโ€™s discretion) for a period or periods up to a total of 24 months.<br/><br/>CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authorityโ€™s discretion) for a period or periods up to a total of 24 months.<br/><br/>CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A. Period of framework: 1 March 2024 to 31 August 2026 with an option or options to extend (at the Authorityโ€™s discretion) for a period or periods up to a total of 12 months<br/><br/>CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B). Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authorityโ€™s discretion) for a period or periods up to a total of 12 months
What changed
From the official release history
  1. Status changed to complete
    26 Feb 2024, 12:50 GMT
  2. Official notice release published
    26 Feb 2024, 12:50 GMT
  3. tender value changed
    24 Oct 2023, 11:06 BST
  4. Status changed to published status
    24 Oct 2023, 11:06 BST
  5. Official notice release published
    24 Oct 2023, 11:06 BST
  6. Submission deadline changed to published date
    24 Oct 2023, 11:06 BST
  7. Published value updated to ยฃ1,833,333,000
    24 Oct 2023, 10:12 BST
  8. Status changed to active
    24 Oct 2023, 10:12 BST
  9. Official notice release published
    24 Oct 2023, 10:12 BST
  10. Submission deadline changed to 24 Nov 2023, 13:00 GMT
    24 Oct 2023, 10:12 BST
  11. Buyer information updated
    24 Oct 2023, 10:12 BST
Lots and requirements (4)
Published by the contracting authority
  • Lot 1 ยท #1
    CM/PHR/22/5678/01
    cancelled
    Published valueNot published
    CM/PHR/22/5678/01 - NHS Framework for North of England Branded Medicines - Tranche B. Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authorityโ€™s discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 2 ยท #2
    CM/PHR/22/5678/02
    cancelled
    Published valueNot published
    NHS Framework for North of England Branded Medicines - Lot 2. (to transition to Tranche B) Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authorityโ€™s discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 3 ยท #3
    CM/PHR/22/5678/03
    cancelled
    Published valueNot published
    CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A. Period of framework: 1 March 2024 to 31 August 2026 with an option or options to extend (at the Authorityโ€™s discretion) for a period or periods up to a total of 12 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 4 ยท #4
    CM/PHR/22/5678/04
    cancelled
    Published valueNot published
    CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B). Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authorityโ€™s discretion) for a period or periods up to a total of 12 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    26 Feb 2024, 12:50 GMT
  2. Award active
    Not published ยท Not published
  3. Award active
    Not published ยท Not published
  4. Award active
    Not published ยท Not published
  5. Award active
    Not published ยท Not published
  6. Award active
    Not published ยท Not published
  7. Award active
    Not published ยท Not published
  8. Award active
    Not published ยท Not published
  9. Award active
    Not published ยท Not published
  10. Award active
    Not published ยท Not published
  11. Award active
    Not published ยท Not published
  12. Award active
    Not published ยท Not published
  13. Award active
    Not published ยท Not published
  14. Award active
    Not published ยท Not published
  15. Award active
    Not published ยท Not published
  16. Award active
    Not published ยท Not published
  17. Award active
    Not published ยท Not published
  18. Award active
    Not published ยท Not published
  19. Award active
    Not published ยท Not published
  20. Award active
    Not published ยท Not published
  21. Award active
    Not published ยท Not published
  22. Award active
    Not published ยท Not published
  23. Award active
    Not published ยท Not published
  24. Award active
    Not published ยท Not published
  25. Award active
    Not published ยท Not published
  26. Award active
    Not published ยท Not published
  27. Award active
    Not published ยท Not published
  28. Award active
    Not published ยท Not published
  29. Award active
    Not published ยท Not published
  30. Award active
    Not published ยท Not published
  31. Award active
    Not published ยท Not published
  32. Award active
    Not published ยท Not published
  33. Award active
    Not published ยท Not published
  34. Award active
    Not published ยท Not published
  35. Award active
    Not published ยท Not published
  36. Award active
    Not published ยท Not published
  37. Award active
    Not published ยท Not published
  38. Award active
    Not published ยท Not published
  39. Award active
    Not published ยท Not published
  40. Award active
    Not published ยท Not published
  41. Award active
    Not published ยท Not published
  42. Award active
    Not published ยท Not published
  43. Award active
    Not published ยท Not published
  44. Award active
    Not published ยท Not published
  45. Award active
    Not published ยท Not published
  46. Award active
    Not published ยท Not published
  47. Award active
    Not published ยท Not published
  48. Award active
    Not published ยท Not published
  49. Award active
    Not published ยท Not published
  50. Award active
    Not published ยท Not published
  51. Award active
    Not published ยท Not published
  52. Award active
    Not published ยท Not published
  53. Award active
    Not published ยท Not published
  54. Award active
    Not published ยท Not published
  55. Award active
    Not published ยท Not published
  56. Award active
    Not published ยท Not published
  57. Award active
    Not published ยท Not published
  58. Award active
    Not published ยท Not published
  59. Award active
    Not published ยท Not published
  60. Award active
    Not published ยท Not published
  61. Award active
    Not published ยท Not published
  62. Award active
    Not published ยท Not published
  63. Award active
    Not published ยท Not published
  64. Award active
    Not published ยท Not published
  65. Award active
    Not published ยท Not published
  66. Award active
    Not published ยท Not published
  67. Award active
    Not published ยท Not published
  68. Award active
    Not published ยท Not published
  69. Award active
    Not published ยท Not published
  70. Award active
    Not published ยท Not published
  71. Award active
    Not published ยท Not published
  72. Award active
    Not published ยท Not published
  73. Award active
    Not published ยท Not published
  74. Award active
    Not published ยท Not published
  75. Award active
    Not published ยท Not published
  76. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  77. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  78. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  79. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  80. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  81. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  82. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  83. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  84. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  85. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  86. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  87. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  88. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  89. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  90. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  91. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  92. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  93. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  94. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  95. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  96. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  97. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  98. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  99. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  100. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  101. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  102. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  103. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  104. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  105. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  106. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  107. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  108. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  109. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  110. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  111. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  112. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  113. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  114. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  115. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  116. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  117. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  118. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  119. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  120. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  121. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  122. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  123. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  124. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  125. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  126. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  127. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  128. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  129. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  130. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  131. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  132. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  133. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  134. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  135. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  136. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  137. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  138. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  139. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  140. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  141. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  142. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  143. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  144. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  145. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  146. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  147. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  148. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
  149. Contract active
    Signed 26 Jan 2024, 00:00 GMT ยท ยฃ1
Commercial outcome and competition
Awards
Celltrion Healthcare United Kingdom Limited
Not published ยท Not published ยท active
Janssen-Cilag Ltd
Not published ยท Not published ยท active
Eli Lilly and Company Ltd
Not published ยท Not published ยท active
Roche Products Ltd
Not published ยท Not published ยท active
Ipsen
Not published ยท Not published ยท active
Napp Pharmaceuticals Ltd
Not published ยท Not published ยท active
CST Pharma Limited
Not published ยท Not published ยท active
Orifarm UK
Not published ยท Not published ยท active
Teva UK Limited
Not published ยท Not published ยท active
Novo Nordisk
Not published ยท Not published ยท active
Novartis Pharmaceuticals UK Ltd
Not published ยท Not published ยท active
Biogen
Not published ยท Not published ยท active
Zentiva Pharma UK Ltd
Not published ยท Not published ยท active
GlaxoSmithKline UK Limited
Not published ยท Not published ยท active
Celltrion Healthcare United Kingdom Limited
Not published ยท Not published ยท active
Merck Sharpe and Dohme (UK) Limited
Not published ยท Not published ยท active
Accord-UK Ltd
Not published ยท Not published ยท active
Dr.Reddy's Laboratories (UK) Limited
Not published ยท Not published ยท active
Pfizer Ltd
Not published ยท Not published ยท active
Aventis Pharma ltd t/a Sanofi
Not published ยท Not published ยท active
Sun Pharma UK Ltd
Not published ยท Not published ยท active
Sobi (Swedish Orphan Biovitrum Ltd)
Not published ยท Not published ยท active
Neon Healthcare Ltd
Not published ยท Not published ยท active
Galapagos Biotech Ltd
Not published ยท Not published ยท active
Thornton and Ross Ltd
Not published ยท Not published ยท active
AstraZeneca
Not published ยท Not published ยท active
Janssen-Cilag Ltd
Not published ยท Not published ยท active
Eli Lilly and Company Ltd
Not published ยท Not published ยท active
Roche Products Ltd
Not published ยท Not published ยท active
Almirall
Not published ยท Not published ยท active
Orifarm UK
Not published ยท Not published ยท active
Teva UK Limited
Not published ยท Not published ยท active
Novartis Pharmaceuticals UK Ltd
Not published ยท Not published ยท active
Pfizer Ltd
Not published ยท Not published ยท active
Gedeon Richter UK Ltd
Not published ยท Not published ยท active
Amgen Ltd
Not published ยท Not published ยท active
Accord-UK Ltd
Not published ยท Not published ยท active
Pfizer Ltd
Not published ยท Not published ยท active
Sandoz Ltd
Not published ยท Not published ยท active
Vifor Pharma UK Ltd
Not published ยท Not published ยท active
Chugai Pharma UK Ltd
Not published ยท Not published ยท active
Abbvie Ltd
Not published ยท Not published ยท active
Merck Serono Limited
Not published ยท Not published ยท active
Janssen-Cilag Ltd
Not published ยท Not published ยท active
Bayer Plc
Not published ยท Not published ยท active
Roche Products Ltd
Not published ยท Not published ยท active
Ipsen
Not published ยท Not published ยท active
Merz
Not published ยท Not published ยท active
Napp Pharmaceuticals Ltd
Not published ยท Not published ยท active
Pharmacosmos UK Ltd
Not published ยท Not published ยท active
Zentiva Pharma UK Ltd
Not published ยท Not published ยท active
GlaxoSmithKline UK Limited
Not published ยท Not published ยท active
Celltrion Healthcare United Kingdom Limited
Not published ยท Not published ยท active
Merck Sharpe and Dohme (UK) Limited
Not published ยท Not published ยท active
Accord-UK Ltd
Not published ยท Not published ยท active
Sandoz Ltd
Not published ยท Not published ยท active
Dr.Reddy's Laboratories (UK) Limited
Not published ยท Not published ยท active
Pfizer Ltd
Not published ยท Not published ยท active
Aventis Pharma ltd t/a Sanofi
Not published ยท Not published ยท active
Sobi (Swedish Orphan Biovitrum Ltd)
Not published ยท Not published ยท active
Galapagos Biotech Ltd
Not published ยท Not published ยท active
Thornton and Ross Ltd
Not published ยท Not published ยท active
AstraZeneca
Not published ยท Not published ยท active
Janssen-Cilag Ltd
Not published ยท Not published ยท active
Eli Lilly and Company Ltd
Not published ยท Not published ยท active
Roche Products Ltd
Not published ยท Not published ยท active
Aventis Pharma ltd t/a Sanofi
Not published ยท Not published ยท active
Organon Pharmaceuticals UK Ltd
Not published ยท Not published ยท active
Orifarm UK
Not published ยท Not published ยท active
Teva UK Limited
Not published ยท Not published ยท active
Novartis Pharmaceuticals UK Ltd
Not published ยท Not published ยท active
Gedeon Richter UK Ltd
Not published ยท Not published ยท active
Mylan
Not published ยท Not published ยท active
Merck Serono Limited
Not published ยท Not published ยท active
Contracts
CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B)
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B
ยฃ1 ยท signed 26 Jan 2024, 00:00 GMT ยท active
Bid statistics
bids: 21 (lot 1)
bids: 21 (lot 1)
bids: 21 (lot 1)
bids: 21 (lot 1)
bids: 21 (lot 1)
bids: 21 (lot 1)
bids: 21 (lot 1)
bids: 21 (lot 1)
bids: 21 (lot 1)
bids: 21 (lot 1)
bids: 21 (lot 1)
bids: 21 (lot 1)
bids: 21 (lot 1)
bids: 21 (lot 1)
bids: 21 (lot 1)
bids: 21 (lot 1)
bids: 21 (lot 1)
bids: 21 (lot 1)
bids: 21 (lot 1)
electronicBids: 21 (lot 1)
electronicBids: 21 (lot 1)
electronicBids: 21 (lot 1)
electronicBids: 21 (lot 1)
electronicBids: 21 (lot 1)
electronicBids: 21 (lot 1)
electronicBids: 21 (lot 1)
electronicBids: 21 (lot 1)
electronicBids: 21 (lot 1)
electronicBids: 21 (lot 1)
electronicBids: 21 (lot 1)
electronicBids: 21 (lot 1)
electronicBids: 21 (lot 1)
electronicBids: 21 (lot 1)
electronicBids: 21 (lot 1)
electronicBids: 21 (lot 1)
electronicBids: 21 (lot 1)
electronicBids: 21 (lot 1)
electronicBids: 21 (lot 1)
foreignBidsFromEU: 21 (lot 1)
foreignBidsFromEU: 21 (lot 1)
foreignBidsFromEU: 21 (lot 1)
foreignBidsFromEU: 21 (lot 1)
foreignBidsFromEU: 21 (lot 1)
foreignBidsFromEU: 21 (lot 1)
foreignBidsFromEU: 21 (lot 1)
foreignBidsFromEU: 21 (lot 1)
foreignBidsFromEU: 21 (lot 1)
foreignBidsFromEU: 21 (lot 1)
foreignBidsFromEU: 21 (lot 1)
foreignBidsFromEU: 21 (lot 1)
foreignBidsFromEU: 21 (lot 1)
foreignBidsFromEU: 21 (lot 1)
foreignBidsFromEU: 21 (lot 1)
foreignBidsFromEU: 21 (lot 1)
foreignBidsFromEU: 21 (lot 1)
foreignBidsFromEU: 21 (lot 1)
foreignBidsFromEU: 21 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
foreignBidsFromNonEU: 0 (lot 1)
smeBids: 5 (lot 1)
smeBids: 5 (lot 1)
smeBids: 5 (lot 1)
smeBids: 5 (lot 1)
smeBids: 5 (lot 1)
smeBids: 5 (lot 1)
smeBids: 5 (lot 1)
smeBids: 5 (lot 1)
smeBids: 5 (lot 1)
smeBids: 5 (lot 1)
smeBids: 5 (lot 1)
smeBids: 5 (lot 1)
smeBids: 5 (lot 1)
smeBids: 5 (lot 1)
smeBids: 5 (lot 1)
smeBids: 5 (lot 1)
smeBids: 5 (lot 1)
smeBids: 5 (lot 1)
smeBids: 5 (lot 1)
bids: 21 (lot 2)
bids: 21 (lot 2)
bids: 21 (lot 2)
bids: 21 (lot 2)
bids: 21 (lot 2)
bids: 21 (lot 2)
bids: 21 (lot 2)
bids: 21 (lot 2)
bids: 21 (lot 2)
bids: 21 (lot 2)
bids: 21 (lot 2)
bids: 21 (lot 2)
bids: 21 (lot 2)
bids: 21 (lot 2)
bids: 21 (lot 2)
bids: 21 (lot 2)
bids: 21 (lot 2)
bids: 21 (lot 2)
bids: 21 (lot 2)
bids: 21 (lot 2)
bids: 21 (lot 2)
electronicBids: 21 (lot 2)
electronicBids: 21 (lot 2)
electronicBids: 21 (lot 2)
electronicBids: 21 (lot 2)
electronicBids: 21 (lot 2)
electronicBids: 21 (lot 2)
electronicBids: 21 (lot 2)
electronicBids: 21 (lot 2)
electronicBids: 21 (lot 2)
electronicBids: 21 (lot 2)
electronicBids: 21 (lot 2)
electronicBids: 21 (lot 2)
electronicBids: 21 (lot 2)
electronicBids: 21 (lot 2)
electronicBids: 21 (lot 2)
electronicBids: 21 (lot 2)
electronicBids: 21 (lot 2)
electronicBids: 21 (lot 2)
electronicBids: 21 (lot 2)
electronicBids: 21 (lot 2)
electronicBids: 21 (lot 2)
foreignBidsFromEU: 21 (lot 2)
foreignBidsFromEU: 21 (lot 2)
foreignBidsFromEU: 21 (lot 2)
foreignBidsFromEU: 21 (lot 2)
foreignBidsFromEU: 21 (lot 2)
foreignBidsFromEU: 21 (lot 2)
foreignBidsFromEU: 21 (lot 2)
foreignBidsFromEU: 21 (lot 2)
foreignBidsFromEU: 21 (lot 2)
foreignBidsFromEU: 21 (lot 2)
foreignBidsFromEU: 21 (lot 2)
foreignBidsFromEU: 21 (lot 2)
foreignBidsFromEU: 21 (lot 2)
foreignBidsFromEU: 21 (lot 2)
foreignBidsFromEU: 21 (lot 2)
foreignBidsFromEU: 21 (lot 2)
foreignBidsFromEU: 21 (lot 2)
foreignBidsFromEU: 21 (lot 2)
foreignBidsFromEU: 21 (lot 2)
foreignBidsFromEU: 21 (lot 2)
foreignBidsFromEU: 21 (lot 2)
foreignBidsFromNonEU: 0 (lot 2)
foreignBidsFromNonEU: 0 (lot 2)
foreignBidsFromNonEU: 0 (lot 2)
foreignBidsFromNonEU: 0 (lot 2)
foreignBidsFromNonEU: 0 (lot 2)
foreignBidsFromNonEU: 0 (lot 2)
foreignBidsFromNonEU: 0 (lot 2)
foreignBidsFromNonEU: 0 (lot 2)
foreignBidsFromNonEU: 0 (lot 2)
foreignBidsFromNonEU: 0 (lot 2)
foreignBidsFromNonEU: 0 (lot 2)
foreignBidsFromNonEU: 0 (lot 2)
foreignBidsFromNonEU: 0 (lot 2)
foreignBidsFromNonEU: 0 (lot 2)
foreignBidsFromNonEU: 0 (lot 2)
foreignBidsFromNonEU: 0 (lot 2)
foreignBidsFromNonEU: 0 (lot 2)
foreignBidsFromNonEU: 0 (lot 2)
foreignBidsFromNonEU: 0 (lot 2)
foreignBidsFromNonEU: 0 (lot 2)
foreignBidsFromNonEU: 0 (lot 2)
smeBids: 4 (lot 2)
smeBids: 4 (lot 2)
smeBids: 4 (lot 2)
smeBids: 4 (lot 2)
smeBids: 4 (lot 2)
smeBids: 4 (lot 2)
smeBids: 4 (lot 2)
smeBids: 4 (lot 2)
smeBids: 4 (lot 2)
smeBids: 4 (lot 2)
smeBids: 4 (lot 2)
smeBids: 4 (lot 2)
smeBids: 4 (lot 2)
smeBids: 4 (lot 2)
smeBids: 4 (lot 2)
smeBids: 4 (lot 2)
smeBids: 4 (lot 2)
smeBids: 4 (lot 2)
smeBids: 4 (lot 2)
smeBids: 4 (lot 2)
smeBids: 4 (lot 2)
bids: 15 (lot 3)
bids: 15 (lot 3)
bids: 15 (lot 3)
bids: 15 (lot 3)
bids: 15 (lot 3)
bids: 15 (lot 3)
bids: 15 (lot 3)
bids: 15 (lot 3)
bids: 15 (lot 3)
bids: 15 (lot 3)
bids: 15 (lot 3)
bids: 15 (lot 3)
bids: 15 (lot 3)
bids: 15 (lot 3)
electronicBids: 15 (lot 3)
electronicBids: 15 (lot 3)
electronicBids: 15 (lot 3)
electronicBids: 15 (lot 3)
electronicBids: 15 (lot 3)
electronicBids: 15 (lot 3)
electronicBids: 15 (lot 3)
electronicBids: 15 (lot 3)
electronicBids: 15 (lot 3)
electronicBids: 15 (lot 3)
electronicBids: 15 (lot 3)
electronicBids: 15 (lot 3)
electronicBids: 15 (lot 3)
electronicBids: 15 (lot 3)
foreignBidsFromEU: 15 (lot 3)
foreignBidsFromEU: 15 (lot 3)
foreignBidsFromEU: 15 (lot 3)
foreignBidsFromEU: 15 (lot 3)
foreignBidsFromEU: 15 (lot 3)
foreignBidsFromEU: 15 (lot 3)
foreignBidsFromEU: 15 (lot 3)
foreignBidsFromEU: 15 (lot 3)
foreignBidsFromEU: 15 (lot 3)
foreignBidsFromEU: 15 (lot 3)
foreignBidsFromEU: 15 (lot 3)
foreignBidsFromEU: 15 (lot 3)
foreignBidsFromEU: 15 (lot 3)
foreignBidsFromEU: 15 (lot 3)
foreignBidsFromNonEU: 0 (lot 3)
foreignBidsFromNonEU: 0 (lot 3)
foreignBidsFromNonEU: 0 (lot 3)
foreignBidsFromNonEU: 0 (lot 3)
foreignBidsFromNonEU: 0 (lot 3)
foreignBidsFromNonEU: 0 (lot 3)
foreignBidsFromNonEU: 0 (lot 3)
foreignBidsFromNonEU: 0 (lot 3)
foreignBidsFromNonEU: 0 (lot 3)
foreignBidsFromNonEU: 0 (lot 3)
foreignBidsFromNonEU: 0 (lot 3)
foreignBidsFromNonEU: 0 (lot 3)
foreignBidsFromNonEU: 0 (lot 3)
foreignBidsFromNonEU: 0 (lot 3)
smeBids: 5 (lot 3)
smeBids: 5 (lot 3)
smeBids: 5 (lot 3)
smeBids: 5 (lot 3)
smeBids: 5 (lot 3)
smeBids: 5 (lot 3)
smeBids: 5 (lot 3)
smeBids: 5 (lot 3)
smeBids: 5 (lot 3)
smeBids: 5 (lot 3)
smeBids: 5 (lot 3)
smeBids: 5 (lot 3)
smeBids: 5 (lot 3)
smeBids: 5 (lot 3)
bids: 20 (lot 4)
bids: 20 (lot 4)
bids: 20 (lot 4)
bids: 20 (lot 4)
bids: 20 (lot 4)
bids: 20 (lot 4)
bids: 20 (lot 4)
bids: 20 (lot 4)
bids: 20 (lot 4)
bids: 20 (lot 4)
bids: 20 (lot 4)
bids: 20 (lot 4)
bids: 20 (lot 4)
bids: 20 (lot 4)
bids: 20 (lot 4)
bids: 20 (lot 4)
bids: 20 (lot 4)
bids: 20 (lot 4)
bids: 20 (lot 4)
bids: 20 (lot 4)
electronicBids: 20 (lot 4)
electronicBids: 20 (lot 4)
electronicBids: 20 (lot 4)
electronicBids: 20 (lot 4)
electronicBids: 20 (lot 4)
electronicBids: 20 (lot 4)
electronicBids: 20 (lot 4)
electronicBids: 20 (lot 4)
electronicBids: 20 (lot 4)
electronicBids: 20 (lot 4)
electronicBids: 20 (lot 4)
electronicBids: 20 (lot 4)
electronicBids: 20 (lot 4)
electronicBids: 20 (lot 4)
electronicBids: 20 (lot 4)
electronicBids: 20 (lot 4)
electronicBids: 20 (lot 4)
electronicBids: 20 (lot 4)
electronicBids: 20 (lot 4)
electronicBids: 20 (lot 4)
foreignBidsFromEU: 20 (lot 4)
foreignBidsFromEU: 20 (lot 4)
foreignBidsFromEU: 20 (lot 4)
foreignBidsFromEU: 20 (lot 4)
foreignBidsFromEU: 20 (lot 4)
foreignBidsFromEU: 20 (lot 4)
foreignBidsFromEU: 20 (lot 4)
foreignBidsFromEU: 20 (lot 4)
foreignBidsFromEU: 20 (lot 4)
foreignBidsFromEU: 20 (lot 4)
foreignBidsFromEU: 20 (lot 4)
foreignBidsFromEU: 20 (lot 4)
foreignBidsFromEU: 20 (lot 4)
foreignBidsFromEU: 20 (lot 4)
foreignBidsFromEU: 20 (lot 4)
foreignBidsFromEU: 20 (lot 4)
foreignBidsFromEU: 20 (lot 4)
foreignBidsFromEU: 20 (lot 4)
foreignBidsFromEU: 20 (lot 4)
foreignBidsFromEU: 20 (lot 4)
foreignBidsFromNonEU: 0 (lot 4)
foreignBidsFromNonEU: 0 (lot 4)
foreignBidsFromNonEU: 0 (lot 4)
foreignBidsFromNonEU: 0 (lot 4)
foreignBidsFromNonEU: 0 (lot 4)
foreignBidsFromNonEU: 0 (lot 4)
foreignBidsFromNonEU: 0 (lot 4)
foreignBidsFromNonEU: 0 (lot 4)
foreignBidsFromNonEU: 0 (lot 4)
foreignBidsFromNonEU: 0 (lot 4)
foreignBidsFromNonEU: 0 (lot 4)
foreignBidsFromNonEU: 0 (lot 4)
foreignBidsFromNonEU: 0 (lot 4)
foreignBidsFromNonEU: 0 (lot 4)
foreignBidsFromNonEU: 0 (lot 4)
foreignBidsFromNonEU: 0 (lot 4)
foreignBidsFromNonEU: 0 (lot 4)
foreignBidsFromNonEU: 0 (lot 4)
foreignBidsFromNonEU: 0 (lot 4)
foreignBidsFromNonEU: 0 (lot 4)
smeBids: 4 (lot 4)
smeBids: 4 (lot 4)
smeBids: 4 (lot 4)
smeBids: 4 (lot 4)
smeBids: 4 (lot 4)
smeBids: 4 (lot 4)
smeBids: 4 (lot 4)
smeBids: 4 (lot 4)
smeBids: 4 (lot 4)
smeBids: 4 (lot 4)
smeBids: 4 (lot 4)
smeBids: 4 (lot 4)
smeBids: 4 (lot 4)
smeBids: 4 (lot 4)
smeBids: 4 (lot 4)
smeBids: 4 (lot 4)
smeBids: 4 (lot 4)
smeBids: 4 (lot 4)
smeBids: 4 (lot 4)
smeBids: 4 (lot 4)
Buyer and organisations in this procedure

NHS England

Contracting authority GB-FTS-3022
View buyer profile
  • NHS England
    buyer
    centralPurchasingBody

    Quarry House, Quarry Hill, Leeds, UK, LS2 7UE
  • Abbvie Ltd
    supplier

    08004972
    Abbvie House, Vanwall Business Park, Vanwall Road,, Maidenhead, Berks., UK, SL6 4UB
  • Accord-UK Ltd
    supplier

    00079585
    Whiddon Valley,, Barnstaple, Devon,, UK, EX32 8NS
  • Almirall
    supplier

    06320852
    Harman House, 1 Goerge Street,, Uxbridge,, UK, UB81QQ
  • Amgen Ltd
    supplier

    2354269 No
    216 Science Park Milton Road, Cambridge, UK, CB4 0WA
  • AstraZeneca
    supplier

    03674842
    Supply Chain, 2 Pancras Square, 8th Floor,, London,, UK, N1C 4AG
  • Aventis Pharma ltd t/a Sanofi
    supplier

    01535640
    410 Thames Valley, Park Drive,, Reading, Berkshire, UK, RG6 1PT
  • Bayer Plc
    supplier

    00935048 No
    400 South Oak Way, Green Park,, Reading, UK, RG2 6AD
  • Biogen
    supplier

    01497267
    Biogen Building 5 Foundation Park, Roxborough Way,, Maidenhead, Berkshire, England,, UK, SL6 3UD
  • CST Pharma Limited
    supplier

    04212740
    Unit 5-7 Tintagel Way, Westgate Park Industrial Estate Aldridge,, Walsall,, UK, WS9 8ER
  • Celltrion Healthcare United Kingdom Limited
    supplier

    11685363
    The Switch ,1-7 The Grove,, Slough, UK, SL1 1QP
  • Chugai Pharma UK Ltd
    supplier

    2814621
    Chugai Pharma UK Limited, 2nd Floor, Mulliner House, Flanders Road, Turnham Green, London, UK, W4 1NN
  • Dr.Reddy's Laboratories (UK) Limited
    supplier

    1729064
    410, Cambridge Science Park Milton Rd, Milton,, Cambridge, UK, CB4 0PE
  • Eli Lilly and Company Ltd
    supplier

    00284385
    Lilly House, Basing View,, Basingstoke, Hampshire,, UK, RG21 4FA
  • Galapagos Biotech Ltd
    supplier

    03400161
    Salisbury House Station Road,, Cambridge Cambridgeshire,, UK, CB1 2LA
  • Gedeon Richter UK Ltd
    supplier

    04325685
    127 Shirland Rd Maida Vale, London, UK, W9 2EP
  • GlaxoSmithKline UK Limited
    supplier

    04310159
    980 Great West Road,, London,, UK, TW8 9GS
  • Ipsen
    supplier

    06751069
    Ipsen Ltd, 190 Bath Road,, Slough,, UK, SL1 3XE
  • Janssen-Cilag Ltd
    supplier

    1027904
    50-100 Holmers Farm Way,, HighWycombe,, UK, HP12 4EG
  • Merck Serono Limited
    supplier

    00990823
    Merck Serono Limited, 5 New Square, Bedfont Lakes Business Park,, Feltham, Middlesex,, UK, TW14 8HA
  • Merck Sharpe and Dohme (UK) Limited
    supplier

    00233687
    120 Moorgate,, London, United Kingdom, UK, EC2M 6UR
  • Merz
    supplier

    4703428
    Suite B, Breakspear Park, 39 Breakspear Way,, Hemel Hempstead,, UK, HP2 4TZ
  • Mylan
    supplier

    09189103
    Building 4, Trident Place, Mosquito Way,, Hatfield, UK, AL10 9UL
  • Napp Pharmaceuticals Ltd
    supplier

    03690299
    Unit 198 Cambridge Science Park, Milton Road,, Cambridge, England,, UK, CB4 0AB
  • Neon Healthcare Ltd
    supplier

    06844351
    8 The Chase, John Tate Road, Foxholes Business Park, Hertford,, Hertfordshire, England,, UK, SG13 7NN
  • Novartis Pharmaceuticals UK Ltd
    supplier

    00119006
    2nd Floor, The Westworks Building, White City Place, 195 Wood Lane,, London,, UK, W12 7FQ
  • Novo Nordisk
    supplier

    01118740
    3 City Place, Beehive Ring Road,, Gatwick, West Sussex,, UK, RH6 0PA,
  • Organon Pharmaceuticals UK Ltd
    supplier

    00820771
    The Hewett Building, 14 Hewett Street,, London, UK, EC2A 3NP
  • Orifarm UK
    supplier

    10015046
    Suite A2 Breakspear Park,, Hemel Hempstead, Hertfordshire,, UK, HP2 4TZ
  • Pfizer Ltd
    supplier

    526209
    Ramsgate Road,, Sandwich, Kent,, UK, CT13 9NJ
  • Pharmacosmos UK Ltd
    supplier

    03104505
    Pharmacosmos UK The White Building 33 Kings Road, Reading, Berkshire,, UK, RG1 3AR
  • Roche Products Ltd
    supplier

    00100674
    Hexagon Place 6 Falcon Way, Shire Park, Welwyn Garden City, UK, AL7 1TW
  • Sandoz Ltd
    supplier

    01547204
    Park View, Riverside Way, Watchmoor Park,, Camberley, Surrey., UK, GU15 3YL
  • Sobi (Swedish Orphan Biovitrum Ltd)
    supplier

    04369760
    Suite 2, Riverside 3, Granta Park,, Great Abington, Cambridgeshire., UK, CB21 6AD
  • Sun Pharma UK Ltd
    supplier

    02992795
    6-9 The Square, Stockley Park,, Uxbridge, UK, UB11 1FW
  • Teva UK Limited
    supplier

    302461
    Ridings Point, Whistler Drive,, Castleford,, UK, WF10 5HX
  • The High Court
    reviewBody

    The Strand, London, WC2A 2LL
  • Thornton and Ross Ltd
    supplier

    185947
    Linthwaite Laboratories, Manchester Road, Linthwaite,, Huddersfield, UK, HD7 5QH
  • Vifor Pharma UK Ltd
    supplier

    06514784
    5 New Street Square, London, UK, EC4A 3TW
  • Zentiva Pharma UK Ltd
    supplier

    2158996
    12 New Fetter Lane,, London, UK, EC4A 1JP
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published